101 results on '"Loughran Jr, Thomas P."'
Search Results
2. CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
3. miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia
4. Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia
5. IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
6. Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia.
7. Retrovirus insertion site analysis of LGL leukemia patient genomes
8. Faculty Opinions recommendation of STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation.
9. Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia.
10. miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia
11. Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent.
12. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human
13. Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis.
14. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL)
15. Faculty Opinions recommendation of Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia.
16. Faculty Opinions recommendation of Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice.
17. Faculty Opinions recommendation of A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.
18. Faculty Opinions recommendation of Functional genomic landscape of acute myeloid leukaemia.
19. Faculty Opinions recommendation of Sphingolipid metabolism in cancer signalling and therapy.
20. Faculty Opinions recommendation of A 17-gene stemness score for rapid determination of risk in acute leukaemia.
21. Faculty Opinions recommendation of AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
22. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
23. Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression
24. C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia
25. Does IL-15 have a causative role in large granular lymphocyte leukemia?
26. Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib
27. Estimation of Daily Proteinuria in Patients with Multiple Myeloma by Using the Protein-to-Creatinine Ratio in Random Urine Samples
28. Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
29. Identification of indels in next-generation sequencing data.
30. Impact of Genetic Targets on Cancer Therapy in Acute Myelogenous Leukemia.
31. Large Granular Lymphocyte Leukemia – From Molecular Pathogenesis to Targeted Therapy.
32. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.
33. Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice
34. Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression.
35. Large granular lymphocyte leukaemia occurring after renal transplantation
36. Spontaneous resolution of p58/EB6 antigen restricted NK‐type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection
37. Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia.
38. Sera of Patients with Rheumatoid Arthritis Contain Antibodies to Recombinant Human T-Lymphotrophic Virus Type I/II Envelope Glycoprotein p21
39. The spectrum of large granular lymphocyte leukemia and Felty's syndrome.
40. Beyond the CRAB Symptoms: A Study of Presenting Clinical Manifestations of Multiple Myeloma.
41. Never Say Die: Survival Signaling in Large Granular Lymphocyte Leukemia.
42. DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia.
43. Network model of survival signaling in large granular lymphocyte leukemia.
44. Liver Injury During Acute Pancreatitis: The Role of Pancreatitis-Associated Ascitic Fluid (PAAF), p38-MAPK, and Caspase-3 in Inducing Hepatocyte Apoptosis
45. Microarray results: how accurate are they?
46. Acquired inhibitors to factor VIII and fibrinogen in the setting of T-cell large granular lymphocyte leukemia: a case report and review of the literature.
47. The quality of medical evidence in hematology-oncology.
48. Leukemia of Large Granular Lymphocytes: Association with Clonal Chromosomal Abnormalities and Autoimmune Neutropenia, Thrombocytopenia, and Hemolytic Anemia.
49. Large granular lymphocytic leukemia: An overview.
50. FACILITATION OF ENGRAFTMENT OF DLA-NONIDENTICAL MARROW BY TREATMENT OF RECIPIENTS WITH MONOCLONAL ANTIBODY DIRECTED AGAINST MARROW CELLS SURVIVING RADIATION.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.